Genprex, Inc. (GNPX)
Nasdaq: GNPX · Pharmaceutical Preparations · Austin, TX · filing with the SEC since 2013
Who runs Genprex, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Confer Ryan M.
President, CEO and CFO. First filing Mar 2018, latest Feb 27, 2026, 0 filings in all.
Officers reporting now
2
of 5 people with a filing in the last fifteen months
Directors reporting now
3
14 people on the record since 2018
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Confer Ryan M. | President, CEO and CFO | Mar 2018 | Feb 27, 2026 | none |
| Berger Mark Stanley | Chief Medical Officer | Sep 2021 | Feb 27, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Longnecker Brent M | director | Mar 2020 | Apr 15, 2026 | 2 · $0.00 |
| Moreno Toscano Jose Antonio | director | Mar 2020 | Dec 23, 2025 | none |
| Wilson William R Jr. | director | Mar 2020 | Dec 23, 2025 | none |
Earlier names on the record12, newest filing first
Varner John Rodney · officer · last filing Feb 2024Vaczy Catherine M · officer · last filing Apr 2023Kumar Hermant · officer · last filing Feb 2023Redman Michael Thomas · officer · last filing Mar 2021Friedman David E. · director · last filing Mar 2020Pearson Robert W. · director · last filing Mar 2020Bonfiglio John N · director · last filing Feb 2019Roth Jack A · 10% owner · last filing Feb 2019Pham Julien L · officer · last filing Jan 2019Genprex, Inc. · officer · last filing Nov 2018Ly Viet-An Hoan · 10% owner · last filing Oct 2018Nance Christy M. · 10% owner · last filing Apr 2018
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.